anti-human CD123 mAb (Crown Bioscience)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-human CD123 mAb (Crown Bioscience)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionInterleukin-3 receptor subunit alpha inhibitors
TargetsInterleukin-3 receptor subunit alpha
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrown Bioscience(Taicang)Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrown Bioscience(Taicang)Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A